Seragon names Tony Coles to board
This article was originally published in Scrip
Executive Summary
San Diego-based Seragon Pharmaceuticals, a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, has named N Anthony (Tony) Coles to its board of directors. Most recently, Dr Coles was president, chief executive officer and chair of the board of Onyx Pharmaceuticals, a global biopharmaceutical company acquired by Amgen in October 2013. He is currently a member of the board of directors of McKesson Corporation, vice-chair of the board of trustees for Johns Hopkins University, and a member of the board of trustees for Johns Hopkins Medicine. Dr Coles is also a member of the board of the US Olympic and Paralympic Foundation.